Market Size & Forecast Global Market Value (2025): USD 65.85 Billion Expected Market Value (2033): USD 236.82 Billion Forecast CAGR (20262033): 17.35% Leading Region in 2025: North America Fastest Growing Region: Asia-Pacific Key Market Trends & Insights North America dominated the Glucagon-Like Peptide 1 (GLP-1) Agonists Market with the largest revenue share of 41.38% in 2025, supported by the high prevalence of type 2 diabetes and obesity, strong adoption of innovative GLP-1 therapies, favorable reimbursement frameworks, and the presence of major pharmaceutical manufacturers
Coenzyme Q10 supplementation in statin treated patients: a double-blinded randomized placebo-controlled trial
Nausea, vomiting, constipation, and diarrhea increase in frequency and intensity at higher doses, especially during dose transitions
The polymorphism has been found to be associated with colorectal cancer susceptibility 19 and survival after diagnosis of breast cancer
Despite the positive results, due to the limited number of included studies, further randomized controlled trials are needed to investigate the safety and efficacy of SGLT2i and GLP-1RAs as first-line treatment options for patients with T2DM at low cardiovascular disease risk, particularly when compared to metformin
